MD Anderson Cancer Center: Large-Scale Cancer Proteomics Study Profiles Protein Changes in Response to Drug Treatments
November 06, 2020
November 06, 2020
HOUSTON, Texas, Nov. 6 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Nov. 5:
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies.
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies.